Reliability and validity of a depression rating scale for schizophrenics, Schizophr. Res, vol.6, pp.201-208, 1992. ,
Drug-induced sexual dysfunction, Clin. Pharm, vol.1, pp.141-147, 1982. ,
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort, Schizophr. Res, vol.185, pp.173-181, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01792072
Adjusting for multiple testing-when and how?, J. Clin. Epidemiol, vol.54, pp.343-349, 2001. ,
Male Sexual Function and Smoking. Sex, Med. Rev, vol.4, pp.366-375, 2016. ,
,
,
Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset, Schizophr. Bull, vol.42, pp.1290-1302, 2016. ,
,
Sexual functioning, psychopathology and quality of life in patients with schizophrenia, Schizophr. Res, vol.94, pp.119-127, 2007. ,
Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort, Br. J. Psychiatry J. Ment. Sci, vol.213, pp.464-470, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01814845
Chronic lowgrade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort, Eur. Arch. Psychiatry Clin. Neurosci, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02336999
FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2016. Peripheral subinflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set, J. Affect. Disord, vol.191, pp.209-215 ,
Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review, Acta Psychiatr. Scand, vol.129, pp.163-179, 2014. ,
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort, Schizophr. Res, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01755227
Metabolic Syndrome and Illness Severity Predict Relapse at 1-Year Follow-Up in Schizophrenia: The FACE-SZ Cohort, J. Clin. Psychiatry, vol.79, 2018. ,
Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder, J. Clin. Psychiatry, vol.68, pp.361-367, 2007. ,
Quality of erections by age group in men with erectile dysfunction, Int. J. Clin. Pract, vol.71, 2017. ,
Comparing effects of a lowenergy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men, J. Sex. Med, vol.8, pp.2868-2875, 2011. ,
Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS), J. Affect. Disord, vol.58, pp.107-115, 2000. ,
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone, Neuropsychiatr. Dis. Treat, vol.5, pp.47-54, 2009. ,
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome, J. Endocrinol. Invest, vol.41, pp.1249-1258, 2018. ,
,
Sexual dysfunction factors in patients with schizophrenia treated with second generation antipsychotics: not only prolactin, Actas Esp. Psiquiatr, vol.46, pp.217-225, 2018. ,
FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group, 2016. Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset, J. Clin. Psychiatry, vol.77, pp.1130-1136 ,
,
, , 2014.
, , vol.43, pp.1111-1115, 1983.
DHEA Modulates Immune Function: A Review of Evidence, Vitam. Horm, vol.108, pp.125-144, 2018. ,
,
How Hyperprolactinemia Affects Sexual Function in Patients Under Antipsychotic Treatment, J. Clin. Psychopharmacol, vol.36, pp.422-428, 2016. ,
Dehydroepiandrosterone (DHEA): hypes and hopes, Drugs, vol.74, pp.1195-1207, 2014. ,
Six months of daily treatment with vardenafil improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, prospective trial, Eur. J. Endocrinol, vol.174, pp.513-522, 2016. ,
,
FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, 2018. ,
,
FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators, 2015. A National network of schizophrenia expert centres: An innovative tool to bridge the researchpractice gap, Eur. Psychiatry J. Assoc. Eur. Psychiatr ,
Sexual dysfunction in patients taking conventional antipsychotic medication, Br. J. Psychiatry J. Ment. Sci, vol.181, pp.49-55, 2002. ,
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis, Psychoneuroendocrinology, vol.93, pp.8-19, 2018. ,
Management of common adverse effects of antipsychotic medications. World Psychiatry Off, J. World Psychiatr. Assoc. WPA, vol.17, pp.341-356, 2018. ,
Sexual dysfunction in patients with schizophrenia on antipsychotic medication, Eur. Psychiatry J. Assoc. Eur. Psychiatr, vol.22, pp.328-333, 2007. ,